Ra Medical Systems Inc.

AMEX: RMED · Real-Time Price · USD
0.59
0.05 (9.26%)
At close: Aug 17, 2023, 10:00 PM

Ra Medical Systems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
420K 14K 22K
Cost of Revenue
42K 161K 1.56M
Gross Profit
378K -147K -1.54M
Operating Income
-11.24M -26.96M -29.27M
Interest Income
81K n/a n/a
Pretax Income
-13.5M -26.86M -27.26M
Net Income
-21.8M -26.86M -27.26M
Selling & General & Admin
11.35M 16.25M 15.47M
Research & Development
272K 6.39M 12.25M
Other Expenses
n/a 99K n/a
Operating Expenses
11.62M 22.64M 27.73M
Interest Expense
-91K 3.08M n/a
Selling & Marketing Expenses
n/a 1.25M n/a
Cost & Expenses
11.66M 22.8M 29.29M
Income Tax Expense
3.14M 3K 4K
Shares Outstanding (Basic)
3.26M 1.03M 101K
Shares Outstanding (Diluted)
3.26M 1.03M 101K
EPS (Basic)
-6.68 -25.98 -269.91
EPS (Diluted)
-6.68 -25.98 -269.91
EBITDA
-11.24M -18.2M -29.27M
EBIT
n/a -23.69M n/a
Depreciation & Amortization
n/a 8.77M 1.56M